Skip Navigation
Skip to contents

J Korean Med Sci.  2012 Oct;27(10):1273-1277. 10.3346/jkms.2012.27.10.1273.

A Case of 9.7 Mb Terminal Xp Deletion Including OA1 Locus Associated with Contiguous Gene Syndrome

Affiliations
  • 1Greencross Reference Laboratory, Seoul, Korea.
  • 2Department of Ophthalmology, Catholic University of Daegu School of Medicine, Daegu, Korea.
  • 3Department of Pediatrics, Catholic University of Daegu School of Medicine, Daegu, Korea. kimjk@cu.ac.kr

Abstract

Terminal or interstitial deletions of Xp (Xp22.2-->Xpter) in males have been recognized as a cause of contiguous gene syndromes showing variable association of apparently unrelated clinical manifestations such as Leri-Weill dyschondrosteosis (SHOX), chondrodysplasia punctata (CDPX1), mental retardation (NLGN4), ichthyosis (STS), Kallmann syndrome (KAL1), and ocular albinism (GPR143). Here we present a case of a 13.5 yr old boy and sister with a same terminal deletion of Xp22.2 resulting in the absence of genes from the telomere of Xp to GPR143 of Xp22. The boy manifested the findings of all of the disorders mentioned above. We began a testosterone enanthate monthly replacement therapy. His sister, 11 yr old, manifested only Leri-Weill dyschondrosteosis, and had engaged in growth hormone therapy for 3 yr. To the best of our knowledge, this is the first report of a male with a 9.7 Mb terminal Xp deletion including the OA1 locus in Korea.

Keyword

Deletion Xp22 pter; Leri-Weill Dyschondrosteosis; Chondrodysplasia Punctata; Mental Retardation; Ichthyosis; Kallmann Syndrome; Ocular Albinism

MeSH Terms

Abnormalities, Multiple/*genetics
Adolescent
Child
Chromosome Deletion
*Chromosomes, Human, X
Eye Proteins/genetics
Female
Genetic Loci
Growth Hormone/therapeutic use
Humans
Male
Membrane Glycoproteins/genetics
Telomere/genetics
WAGR Syndrome/*diagnosis/genetics/therapy
Eye Proteins
Membrane Glycoproteins
Growth Hormone
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr